Oral versus im administration of high-dose medroxyprogesterone acetate in pretreated patients with advanced breast cancer.
Beex L, Burghouts J, van Turnhout J, Breed W, Hillen H, Holdrinet A, Boetius G, Hoogendoorn G, Doesburg W, Verhulst M, et al.
Cancer Treat Rep. 1987 Dec;71(12):1151-6.PMID: 3690524 [PubMed - indexed for MEDLINE]Related articles